Clinical Trial Update: Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study [Phase 4]

View source ↗

Summary

Phase 4 study evaluating oral amiodarone for acute cardioversion in atrial fibrillation has been terminated. The sponsor is the University of Calgary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Amiodarone (amiodarone)

Snippet

Sponsor: University of Calgary | Conditions: Atrial Fibrillation | Phase 4 | Status: TERMINATED